An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China-Reference-Cited by-同舟云学术

An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China

Published:2017-04 Issue: Volume:69 Page:126-132
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Yu Peimin,Zhou Dong,Liao Weiping,Wang Xin,Wang Yuping,Wang Tiancheng,Wu Yuan,Lang Senyang,Lin Weihong,Song Yijun,Zhao Heqing,Cai Meng,Hong Zhen

Funder

GSK

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference48 articles.

1. Prevalence of epilepsy in the People's Republic of China: a systematic review;Gu;Epilepsy Res,2013

2. Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy;Gao;Epilepsy Res,2015

3. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China;Hong;Epilepsia,2009

4. Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care;St Louis;Curr Neuropharmacol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and treatment of midlife‐onset epilepsy: A 24‐year single‐center, retrospective study;Epileptic Disorders;2024-06-19

2. Quality indicators for epilepsy management in China: The development of a tool to assess care and first three-year report;Epilepsy Research;2024-02

3. Pregnancy characteristics and adverse outcomes in offspring of women with epilepsy: a prospective registry study from Mainland China;Frontiers in Neurology;2023-08-11

4. Demographic and Clinical Predictors of Drug Response in Epileptic Children in Jeddah;Biomedicines;2023-07-30

5. Therapeutic Drug Monitoring of Perampanel in Children With Refractory Epilepsy: Focus on Influencing Factors on the Free-Perampanel Concentration;Therapeutic Drug Monitoring;2023-04-20